{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T03:22:32Z","timestamp":1772248952564,"version":"3.50.1"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>A vaccine is considered essential for controlling the HIV pandemic and ultimately eradicating AIDS. Neutralizing antibodies and MHC-E-restricted CD8+ T cells have shown the ability to protect against the simian counterpart of HIV, SIV, in rhesus macaques. In this study, we provide preliminary evidence that combining these orthogonal antiviral mechanisms can offer increased protection against SIV. Specifically, the replication arrest observed following vaccination with a rhesus cytomegalovirus (RhCMV\/SIV)-based vaccine was enhanced by the presence of a passively administered neutralizing antibody at incompletely protective levels. This report encourages studies involving larger cohorts of macaques and alternative methods for administering neutralizing antibodies.<\/jats:p>","DOI":"10.3389\/fmicb.2025.1592647","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T01:23:56Z","timestamp":1748827436000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Combining a rhesus cytomegalovirus\/SIV vaccine with a neutralizing antibody to protect against SIV challenges in rhesus macaques"],"prefix":"10.3389","volume":"16","author":[{"given":"Jessica","family":"Coppola","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mara","family":"Parren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raiza","family":"Bastidas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Saye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline","family":"Malvin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph G.","family":"Jardine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roxanne M.","family":"Gilbride","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sohita","family":"Ojha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shana","family":"Feltham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Morrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron","family":"Barber-Axthelm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachele","family":"Bochart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randy","family":"Fast","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelli","family":"Oswald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Shoemaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey D.","family":"Lifson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louis J.","family":"Picker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis R.","family":"Burton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott G.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,2]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.cell.2020.08.033","article-title":"Passive transfer of vaccine-elicited antibodies protects against SIV in Rhesus macaques","volume":"183","author":"Alter","year":"2020","journal-title":"Cell"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/nature12744","article-title":"Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys","volume":"503","author":"Barouch","year":"2013","journal-title":"Nature"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1128\/JVI.02454-15","article-title":"Human immunodeficiency virus type 1 monoclonal antibodies suppress acute simian-human immunodeficiency virus viremia and limit seeding of cell-associated viral reservoirs","volume":"90","author":"Bolton","year":"2016","journal-title":"J. Virol."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/s41577-023-00858-w","article-title":"Antiviral neutralizing antibodies: from in vitro to in vivo activity","volume":"23","author":"Burton","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.02268-16","article-title":"Structure-based Design of a Soluble Prefusion-Closed HIV-1 Env trimer with reduced CD4 affinity and improved immunogenicity","volume":"91","author":"Chuang","year":"2017","journal-title":"J. Virol."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1097\/COH.0000000000000051","article-title":"The role of fc receptors in HIV infection and vaccine efficacy","volume":"9","author":"Cocklin","year":"2014","journal-title":"Curr. Opin. HIV AIDS"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1056\/NEJMoa2031738","article-title":"Two randomized trials of neutralizing antibodies to prevent HIV-1 acquisition","volume":"384","author":"Corey","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"e1006359","DOI":"10.1371\/journal.ppat.1006359","article-title":"Genetically-barcoded SIV facilitates enumeration of rebound variants and estimation of reactivation rates in nonhuman primates following interruption of suppressive antiretroviral therapy","volume":"13","author":"Fennessey","year":"2017","journal-title":"PLoS Pathog."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"e1008377","DOI":"10.1371\/journal.ppat.1008377","article-title":"Engagement of monocytes, NK cells, and CD4+ Th1 cells by ALVAC-SIV vaccination results in a decreased risk of SIVmac251 vaginal acquisition","volume":"16","author":"Gorini","year":"2020","journal-title":"PLoS Pathog."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"e1011407","DOI":"10.1371\/journal.ppat.1011407","article-title":"Antibody-dependent cellular cytotoxicity, infected cell binding and neutralization by antibodies to the SIV envelope glycoprotein","volume":"19","author":"Grunst","year":"2023","journal-title":"PLoS Pathog."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nature10003","article-title":"Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine","volume":"473","author":"Hansen","year":"2011","journal-title":"Nature"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"eabn9301","DOI":"10.1126\/sciimmunol.abn9301","article-title":"Myeloid cell tropism enables MHC-E-restricted CD8(+) T cell priming and vaccine efficacy by the RhCMV\/SIV vaccine","volume":"7","author":"Hansen","year":"2022","journal-title":"Sci Immunol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaw2607","article-title":"A live-attenuated RhCMV\/SIV vaccine shows long-term efficacy against heterologous SIV challenge","volume":"11","author":"Hansen","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/nature12519","article-title":"Immune clearance of highly pathogenic SIV infection","volume":"502","author":"Hansen","year":"","journal-title":"Nature"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1237874","DOI":"10.1126\/science.1237874","article-title":"Cytomegalovirus vectors violate CD8+ T cell epitope recognition paradigms","volume":"340","author":"Hansen","year":"","journal-title":"Science"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1126\/science.aac9475","article-title":"Broadly targeted CD8+ T cell responses restricted by major histocompatibility complex E","volume":"351","author":"Hansen","year":"2016","journal-title":"Science"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature06106","article-title":"Fc receptor but not complement binding is important in antibody protection against HIV","volume":"449","author":"Hessell","year":"2007","journal-title":"Nature"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1128\/JVI.01272-09","article-title":"Broadly neutralizing monoclonal antibodies 2F5 and 4E10 directed against the human immunodeficiency virus type 1 gp41 membrane-proximal external region protect against mucosal challenge by simian-human immunodeficiency virus SHIVBa-L","volume":"84","author":"Hessell","year":"2010","journal-title":"J. Virol."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1038\/s41467-021-21402-1","article-title":"SIV-induced terminally differentiated adaptive NK cells in lymph nodes associated with enhanced MHC-E restricted activity","volume":"12","author":"Huot","year":"2021","journal-title":"Nat. Commun."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1038\/nm.1967","article-title":"Vector-mediated gene transfer engenders long-lived neutralizing activity and protection against SIV infection in monkeys","volume":"15","author":"Johnson","year":"2009","journal-title":"Nat. Med."},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01420-19","article-title":"Vivo validation of the viral barcoding of simian immunodeficiency virus SIVmac239 and the development of new barcoded SIV and subtype B and C simian-human immunodeficiency viruses","volume":"94","author":"Khanal","year":"2019","journal-title":"J. Virol."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/nature13612","article-title":"Enhanced neonatal fc receptor function improves protection against primate SHIV infection","volume":"514","author":"Ko","year":"2014","journal-title":"Nature"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"12040","DOI":"10.1038\/ncomms12040","article-title":"Uncleaved prefusion-optimized gp140 trimers derived from analysis of HIV-1 envelope metastability","volume":"7","author":"Kong","year":"2016","journal-title":"Nat. Commun."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.4161\/hv.23446","article-title":"Activation of NK cells by HIV-specific ADCC antibodies: role for granulocytes in expressing HIV-1 peptide epitopes","volume":"9","author":"Madhavi","year":"2013","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"eabg5413","DOI":"10.1126\/sciimmunol.abg5413","article-title":"Cytomegaloviral determinants of CD8+ T cell programming and RhCMV\/SIV vaccine efficacy","volume":"6","author":"Malouli","year":"2021","journal-title":"Sci. Immunol."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"449","DOI":"10.3389\/fimmu.2020.00449","article-title":"Long-term delivery of an anti-SIV monoclonal antibody with AAV","volume":"11","author":"Martinez-Navio","year":"2020","journal-title":"Front. Immunol."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"8340","DOI":"10.1128\/JVI.75.17.8340-8347.2001","article-title":"Antibody protects macaques against vaginal challenge with a pathogenic R5 simian\/human immunodeficiency virus at serum levels giving complete neutralization in vitro","volume":"75","author":"Parren","year":"2001","journal-title":"J. Virol."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.immuni.2017.05.007","article-title":"Elicitation of robust tier 2 neutralizing antibody responses in nonhuman Primates by HIV envelope trimer immunization using optimized approaches","volume":"46","author":"Pauthner","year":"2017","journal-title":"Immunity"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.immuni.2018.11.011","article-title":"Vaccine-induced protection from homologous tier 2 SHIV challenge in nonhuman Primates depends on serum-neutralizing antibody titers","volume":"50","author":"Pauthner","year":"2019","journal-title":"Immunity"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.chom.2019.08.014","article-title":"A Meta-analysis of passive immunization studies shows that serum-neutralizing antibody titer associates with protection against SHIV challenge","volume":"26","author":"Pegu","year":"2019","journal-title":"Cell Host Microbe"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.126047","article-title":"Vaccine induction of antibodies and tissue-resident CD8+ T cells enhances protection against mucosal SHIV-infection in young macaques","volume":"4","author":"Petitdemange","year":"2019","journal-title":"JCI Insight"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.it.2023.02.001","article-title":"Programming cytomegalovirus as an HIV vaccine","volume":"44","author":"Picker","year":"2023","journal-title":"Trends Immunol."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1478063","DOI":"10.3389\/fimmu.2024.1478063","article-title":"Acute-phase innate immune responses in SIVmac239-infected Mamu-B*08+ Indian rhesus macaques may contribute to the establishment of elite control","volume":"15","author":"Rosen","year":"2024","journal-title":"Front. Immunol."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1038\/s41467-018-04272-y","article-title":"Structure of a cleavage-independent HIV Env recapitulates the glycoprotein architecture of the native cleaved trimer","volume":"9","author":"Sarkar","year":"2018","journal-title":"Nat. Commun."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"eabo5598","DOI":"10.1126\/scitranslmed.abo5598","article-title":"Stabilized HIV-1 envelope immunization induces neutralizing antibodies to the CD4bs and protects macaques against mucosal infection","volume":"14","author":"Saunders","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"e1003754","DOI":"10.1371\/journal.ppat.1003754","article-title":"The effects of somatic hypermutation on neutralization and binding in the PGT121 family of broadly neutralizing HIV antibodies","volume":"9","author":"Sok","year":"2013","journal-title":"PLoS Pathog."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"101201","DOI":"10.1016\/j.xcrm.2023.101201","article-title":"HIV-1 neutralizing antibodies provide sterilizing immunity by blocking infection of the first cells","volume":"4","author":"Stab","year":"2023","journal-title":"Cell Rep. Med."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"eabe9233","DOI":"10.1126\/science.abe9233","article-title":"Modulation of MHC-E transport by viral decoy ligands is required for RhCMV\/SIV vaccine efficacy","volume":"372","author":"Verweij","year":"2021","journal-title":"Science"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1016\/j.immuni.2022.09.001","article-title":"Human immunoglobulin repertoire analysis guides design of vaccine priming immunogens targeting HIV V2-apex broadly neutralizing antibody precursors","volume":"55","author":"Willis","year":"2022","journal-title":"Immunity"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"5236","DOI":"10.1038\/s41467-022-32783-2","article-title":"Molecular insights into antibody-mediated protection against the prototypic simian immunodeficiency virus","volume":"13","author":"Zhao","year":"2022","journal-title":"Nat. Commun."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2025.1592647\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T01:23:56Z","timestamp":1748827436000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2025.1592647\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,2]]},"references-count":40,"alternative-id":["10.3389\/fmicb.2025.1592647"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2025.1592647","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.03.20.644395","asserted-by":"object"}]},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,2]]},"article-number":"1592647"}}